Last reviewed · How we verify
Lyspamin (nicofetamide)
Lyspamin (generic name: nicofetamide) is a nicofetamide drug. It is currently in unknown development.
Lyspamin works by interacting with a specific target to produce a therapeutic effect.
Lyspamin is a small molecule with synonyms including C 1065, C-1065, LISPAMINA, LYSPAMIN, and NICOFETAMIDE.
At a glance
| Generic name | nicofetamide |
|---|---|
| Drug class | nicofetamide |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Unfortunately, the exact way Lyspamin works is not well understood, but it is thought to affect the body's natural processes in some way to produce its effects.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lyspamin CI brief — competitive landscape report
- Lyspamin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Lyspamin
What is Lyspamin?
How does Lyspamin work?
What is the generic name of Lyspamin?
What drug class is Lyspamin in?
What development phase is Lyspamin in?
Related
- Drug class: All nicofetamide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing